SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-11-032157
Filing Date
2011-05-27
Accepted
2011-05-27 17:01:29
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 a11-13300_2s3.htm S-3 343677
2 EX-5.1 a11-13300_2ex5d1.htm EX-5.1 25501
3 EX-23.1 a11-13300_2ex23d1.htm EX-23.1 2744
4 GRAPHIC g133002ba05i001.jpg GRAPHIC 4393
5 GRAPHIC g133002ba01i001.jpg GRAPHIC 4395
  Complete submission text file 0001104659-11-032157.txt   385399
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-174597 | Film No.: 11878917
SIC: 2836 Biological Products, (No Diagnostic Substances)